Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial
Michael Simons, Brian H. Annex, Roger J. Laham, Neal Kleiman, Timothy Henry, Harold Dauerman, James E. Udelson, Ernesto V. Gervino, Marilyn Pike, M. J. Whitehouse, Thomas Moon, Nicolas A. Chronos
Dive into the research topics of 'Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial'. Together they form a unique fingerprint.